BackHealthlead Public Company Limited Overview
Healthlead Public Company Limited

Healthlead Public Company Limited Return on Equity

Latest ROE for Healthlead Public Company Limited: 6.77% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

6.77%

Return on Equity

6.77%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Healthlead Public Company Limited (HL.BK) FAQ

The latest ROE for HL.BK is 6.77%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Healthlead Public Company Limited's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, HL.BK currently prints 6.77% for ROE, while the sector average sits near 11.3%. That is roughly 40.1% below the sector mean. Large gaps often invite a closer look at Healthlead Public Company Limited's growth, margins, and balance sheet.

Return on Equity shows how effectively Healthlead Public Company Limited converts resources into returns. At 6.77%, HL.BK may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting HL.BK's ROE (6.77%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.